Treatment of chronic graft-versus-host disease with bortezomib

Chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplantation (HSCT) has emerged as a predominant complication following HSCT and has a distinct etiology. We and others have previously demonstrated that bortezomib, a proteasome inhibitor, can prevent but not...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pai, Chien-Chun Steven, Chen, Mingyi, Mirsoian, Annie, Grossenbacher, Steven K., Tellez, Joseph, Ames, Erik, Sun, Kai, Jagdeo, Jared, Blazar, Bruce R., Murphy, William J., Abedi, Mehrdad
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2014
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4155274/
https://ncbi.nlm.nih.gov/pubmed/25009225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-02-554279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados